BioSpace News Archive

South Korean bio-venture BIORCHESTRA Co. Ltd., is an RNA therapeutics firm focused on neurodegeneration. BIORCHESTRA discovered a disease-associated microRNA that was found to be significantly up-regulated in samples from Alzheimer’s disease patients.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named one of the Chicago Tribune’s Top Workplaces 2021 , ranking No. 5 out of 75 other midsize companies in the Chicago area.

An allergy refers to a condition that is caused due to hypersensitivity of the human immune system to some harmless materials.

The global clinical decision support system market is rising with rule based expert system, funding from societies for improving point of care, and increasing primary healthcare support across the globe is expected to drive the growth of market.

In recent months, there is a striking increase in the spread of COVID-19 infection in all worldwide locations.

One of the popular methods of crime detection is the use of forensics technology. The rising influence of forensic technologies in various crime investigation scenarios will present an array of opportunities for the forensic technologies market during the forecast period of 2017-2025.

Inventive technologies and cutting-edge research have led to the development of several innovative magnetic resonance imaging equipment, helping patients live healthier and longer lives.

Smart Immune SAS, a T-cell medicine company utilizing its proprietary ex-vivo biomimetic “thymus in a dish” technology to develop allogeneic T-cell progenitors Smart-101 for rapid immune reconstitution, announced the presentation of clinical data and preclinical research at the 63rd annual meeting of the American Society of Hematology, taking place December 11-14 in Atlanta, Georgia.

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced the pricing of its follow-on public offering of 3,428,571 American Depositary Shares, at a public offering price of $7.00 per ADS, with each such ADS representing one ordinary share, DKK 1 nominal value per share, of Evaxion.

Human cell coding company bit.bio announces the first close of their Series B financing of $103 million.